Which hedge funds own GWPH? GW PHARMACEUTICALS PLC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in GWPH (GW PHARMACEUTICALS PLC) in their Q2 2026 13F filings, worth $0 in total.
- 0
- Holders
- 0
- New this quarter
- 0
- Exited this quarter
- $0
- Combined value
- –
- Share of managers holding
Holders, Q2 2026
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q2 2021 | 0 | 71 | 0.0% | $0 |
| Q1 2021 | 6 | 70 | 8.6% | $928m |
| Q4 2020 | 1 | 71 | 1.4% | $17.9m |
| Q3 2020 | 3 | 68 | 4.4% | $70.0m |
| Q2 2020 | 2 | 68 | 2.9% | $77.0m |
| Q1 2020 | 3 | 68 | 4.4% | $43.8m |
| Q4 2019 | 4 | 67 | 6.0% | $139m |
| Q3 2019 | 4 | 60 | 6.7% | $170m |
| Q2 2019 | 2 | 60 | 3.3% | $117m |
| Q1 2019 | 3 | 60 | 5.0% | $134m |
| Q4 2018 | 3 | 60 | 5.0% | $163m |
| Q3 2018 | 5 | 59 | 8.5% | $288m |
| Q2 2018 | 4 | 59 | 6.8% | $322m |
| Q1 2018 | 3 | 59 | 5.1% | $348m |
| Q4 2017 | 5 | 59 | 8.5% | $542m |
| Q3 2017 | 4 | 56 | 7.1% | $392m |
| Q2 2017 | 5 | 56 | 8.9% | $360m |
| Q1 2017 | 6 | 56 | 10.7% | $389m |
| Q4 2016 | 6 | 56 | 10.7% | $356m |
| Q3 2016 | 4 | 52 | 7.7% | $405m |
| Q2 2016 | 3 | 52 | 5.8% | $215m |
| Q1 2016 | 3 | 52 | 5.8% | $53.9m |
| Q4 2015 | 3 | 52 | 5.8% | $15.3m |
| Q3 2015 | 1 | 52 | 1.9% | $959k |
| Q2 2015 | 1 | 52 | 1.9% | $7.4m |
| Q1 2015 | 1 | 52 | 1.9% | $2.3m |
| Q4 2014 | 0 | 52 | 0.0% | $0 |
| Q3 2014 | 2 | 49 | 4.1% | $20.8m |
| Q2 2014 | 2 | 49 | 4.1% | $42.6m |
| Q1 2014 | 2 | 47 | 4.3% | $41.5m |
| Q4 2013 | 2 | 47 | 4.3% | $24.5m |
| Q3 2013 | 1 | 45 | 2.2% | $10.1m |
| Q2 2013 | 1 | 43 | 2.3% | $4.9m |
Who discovered GWPH first?
Earliest meaningful positions among the 11 tracked managers seen opening GWPH since Q2 2013.
| Scopia Capital Management LP high conviction | Q2 2016 | 3.0% | Exited by Q2 2019 | +23% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.
1 already held it when coverage began
Woodline Partners LP (Q4 2019)